Home > Insider Trading > Filing (0001250853-13-000146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561743	Kindred Biosciences Inc.	KIN	Pharmaceutical Preparations (2834)	461160142

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1454385	Oleg Nodelman	C/O Kindred Biosciences, Inc. 1499 Bayshore Highway, Suite 226 Burlingame CA 94010		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-12	400,000	$7.00	873,187	No	4	P	Indirect	By EcoR1 Capital Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By EcoR1 Capital Fund, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2013-12-11	20,000	$0.00	20,000	$7.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2023-12-11	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	50,000	Direct

Footnotes

These shares were purchased in connection with the Issuer's initial public offering.
Held by EcoR1 Capital Fund, L.P. The sole general partner of EcoR1 Capital Fund, L.P. is EcoR1 Capital, LLC, of which the Reporting Person is the sole managing member. As such, the Reporting Person is deemed to be the beneficial owner of the securities held by EcoR1 Capital Fund, L.P.
Granted pursuant to the Issuer's 2012 Equity Incentive Plan.
5,000 of the shares subject to the option will vest on December 11, 2014, with the remaining shares vesting in equal monthly installments over the ensuing 36 months, subject to the Reporting Person's continuous service as a director.